1-4 of 4
Khalid Mezzi, MD MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib Dosing Patterns and Time to Next Treatment Among Adult Patients with Multiple Myeloma Treated in the US Community Oncology Setting

Robert M Rifkin, MD, E Susan Amirian, PhD MS, Rohan Medhekar, PhD, Thomas Wilson, PhD DrPH, Marley Boyd, MS, Khalid Mezzi, MD MBA, Sumeet Panjabi, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3433.
https://doi.org/10.1182/blood.V130.Suppl_1.3433.3433
Published: 2017
Journal Articles

A Real-World Comparative Analysis of Carfilzomib and Other Systemic Multiple Myeloma Chemotherapies in the US Community Oncology Setting

Robert M Rifkin, MD, Rohan Medhekar, PhD, E Susan Amirian, PhD MS, Thomas Wilson, PhD DrPH, Marley Boyd, MS, Khalid Mezzi, MD MBA, Sumeet Panjabi, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3434.
https://doi.org/10.1182/blood.V130.Suppl_1.3434.3434
Published: 2017
Journal Articles

Demographic and Clinical Characteristics of Multiple Myeloma (MM) Patients Treated with Carfilzomib-Based Regimens in a Real World Setting

Christopher Kim, PhD, Winifred Werther, Karim Saad Iskander, Michael Gruber, Khalid Mezzi, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 5441.
https://doi.org/10.1182/blood.V130.Suppl_1.5441.5441
Published: 2017
Journal Articles

Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study

Meletios A. Dimopoulos, David Siegel, MD PhD, Darrell J. White, MD, Ralph V. Boccia, Zhao Yang, Amy S. Kimball, Karim Saad Iskander, Khalid Mezzi, MD MBA, Heinz Ludwig, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1845.
https://doi.org/10.1182/blood.V130.Suppl_1.1845.1845
Published: 2017